{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-279061","form_type":"8-K","ticker":"INO","cik":"0001055726","company_name":"INOVIO PHARMACEUTICALS, INC.","filed_at":"2024-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.518408+00:00","generated_at":"2026-05-29T02:43:28.385634+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Inovio prices $30M public offering of 10M shares and warrants","bullets":["10M shares at $3.00/share plus warrants to buy 10M shares at $3.76, 5-year term.","Gross proceeds $30M; net proceeds ~$27.6M after discounts and expenses.","Closing expected December 16, 2024, subject to customary conditions.","Warrants include 4.99% beneficial ownership limitation (up to 9.99% on election).","Oppenheimer & Co. and Citizens JMP joint book-runners; Stephens Inc. lead manager."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-279061","json":"https://secwatch.observer/filing/0001193125-24-279061.json","markdown":"https://secwatch.observer/filing/0001193125-24-279061.md","text":"https://secwatch.observer/filing/0001193125-24-279061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1055726/000119312524279061/0001193125-24-279061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1055726/000119312524279061/d899983d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T02:43:28.385634+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}